Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07817446) titled 'Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study' on Sept. 7.
Study Type: Observational
Primary Sponsor: Chulalongkorn University
Condition:
Headache
Migraine
Intervention:
Drug: gender-affirming hormone therapy
Procedure: Gender-Affirming Surgery
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 500
Countries of Recruitment:
Thailand
To know more, visit https://clinicaltrials.gov/study/NCT07817446
Published by HT Digital Content Services with permission from Health Daily Digest....